133 related articles for article (PubMed ID: 16505104)
1. RRR-alpha-tocopherol succinate down-regulates oncogenic Ras signaling.
Donapaty S; Louis S; Horvath E; Kun J; Sebti SM; Malafa MP
Mol Cancer Ther; 2006 Feb; 5(2):309-16. PubMed ID: 16505104
[TBL] [Abstract][Full Text] [Related]
2. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
3. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
[TBL] [Abstract][Full Text] [Related]
4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
6. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention.
Wu Y; Zu K; Ni J; Yeh S; Kasi D; James NS; Chemler S; Ip C
Anticancer Res; 2004; 24(6):3795-802. PubMed ID: 15736414
[TBL] [Abstract][Full Text] [Related]
8. K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival.
Ninomiya Y; Kato K; Takahashi A; Ueoka Y; Kamikihara T; Arima T; Matsuda T; Kato H; Nishida J; Wake N
Cancer Res; 2004 Apr; 64(8):2759-65. PubMed ID: 15087391
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras.
Sommer KW; Schamberger CJ; Schmidt GE; Sasgary S; Cerni C
Oncogene; 2003 Jul; 22(27):4266-80. PubMed ID: 12833149
[TBL] [Abstract][Full Text] [Related]
10. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway.
Sakata K; Kato S; Fox JC; Shigemori M; Morimatsu M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):975-83. PubMed ID: 12430714
[TBL] [Abstract][Full Text] [Related]
11. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Kim IA; Bae SS; Fernandes A; Wu J; Muschel RJ; McKenna WG; Birnbaum MJ; Bernhard EJ
Cancer Res; 2005 Sep; 65(17):7902-10. PubMed ID: 16140961
[TBL] [Abstract][Full Text] [Related]
13. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
Choi C; Kwon J; Lim S; Helfman DM
Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
[TBL] [Abstract][Full Text] [Related]
14. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
15. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway.
Mazzoni IE; Saïd FA; Aloyz R; Miller FD; Kaplan D
J Neurosci; 1999 Nov; 19(22):9716-27. PubMed ID: 10559381
[TBL] [Abstract][Full Text] [Related]
16. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
Kimmelman AC; Osada M; Chan AM
Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
[TBL] [Abstract][Full Text] [Related]
17. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
[TBL] [Abstract][Full Text] [Related]
18. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896
[TBL] [Abstract][Full Text] [Related]
19. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
20. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
Villalonga P; Rius E; Bachs O; Agell N
Oncogene; 2000 Feb; 19(5):690-9. PubMed ID: 10698514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
